Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patients

Alfonso Piciocchi, Marta Cipriani, Monica Messina et al.

2024 · 9 Zit.

Explainable Machine Learning Model to Predict Overall Survival in Patients Treated With Palliative Radiotherapy for Bone Metastases

Savino Cilla, R Rossi, Ragnhild Habberstad et al.

2024 · 3 Zit.

From raw data to research-ready: A FHIR-based transformation pipeline in a real-world oncology setting

Antonella Carbonaro, Luca Giorgetti, Luca Ridolfi et al.

2025 · 1 Zit.

Top three priorities for artificial intelligence integration into emergency, critical, and perioperative medicine: an interdisciplinary clinical expert consensus

Beatrice Loriga, Francesco Baglivo, Valentina Bellini et al.

2025 · 0 Zit.

Is ChatGPT a reliable informant? Dermatologists review AI-generated answers to frequently asked questions about melanoma

Gianluca Pistore, Luca Fania, Giovanni Pellacani et al.

2026 · 0 Zit.

From Paper to Digital: Evaluating Electronic Medical Records and their Compliance with EMA Guidelines in European Clinical Trials

Stefano Stabile, Sara Testoni, Veronica Franchina et al.

2025 · 0 Zit.

Survey on cancer patients’ attitudes towards AI and data protection: A cross-sectional study from an Italian cancer center

Martina Cavallucci, Alice Andalò, Valentina Danesi et al.

2025 · 0 Zit.